英夫利昔单抗治疗克罗恩病期间诱发的急性肝炎：与阿达木单抗无交叉毒性。 - Suppr

Suppr

超能文献

Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.

作者信息

Haennig A, Bonnet D, Thebault S, Alric L

出版信息

Gastroenterol Clin Biol. 2010 Sep;34(8-9):e7-8. doi: 10.1016/j.gcb.2010.01.016. Epub 2010 Feb 26.

DOI:10.1016/j.gcb.2010.01.016

PMID:20189334

Abstract

摘要

相似文献

Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.英夫利昔单抗治疗克罗恩病期间诱发的急性肝炎：与阿达木单抗无交叉毒性。

Gastroenterol Clin Biol. 2010 Sep;34(8-9):e7-8. doi: 10.1016/j.gcb.2010.01.016. Epub 2010 Feb 26.

Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.英夫利昔单抗诱导克罗恩病患者发生自身免疫性肝炎，转换用阿达木单抗后无复发。

BioDrugs. 2010 Dec 14;24 Suppl 1:25-7. doi: 10.2165/11586210-000000000-00000.

Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.英夫利昔单抗和阿达木单抗诱导的克罗恩病银屑病：一种矛盾的副作用。

J Crohns Colitis. 2011 Apr;5(2):157-61. doi: 10.1016/j.crohns.2010.11.001. Epub 2010 Dec 7.

[Adalimumab in Crohn's disease - data from real life].[阿达木单抗治疗克罗恩病——来自现实生活的数据]

Rev Esp Enferm Dig. 2008 Nov;100(11):671-5. doi: 10.4321/s1130-01082008001100001.

Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study.英夫利昔单抗和阿达木单抗治疗克罗恩病的疗效和安全性：一项单中心研究。

Aliment Pharmacol Ther. 2012 Jun;35(12):1397-407. doi: 10.1111/j.1365-2036.2012.05100.x. Epub 2012 Apr 22.

Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.阿达木单抗诱导的狼疮性红斑，发生于既往接受英夫利昔单抗治疗的克罗恩病患者。

Gut. 2008 Apr;57(4):559; author reply 559-60.

First case report of adalimumab-induced psoriasis in Crohn's disease.克罗恩病中阿达木单抗诱发银屑病的首例病例报告。

Am J Gastroenterol. 2009 Mar;104(3):792-3. doi: 10.1038/ajg.2008.101. Epub 2009 Feb 3.

Commentary: infliximab or adalimumab in Crohn's disease?评论：英夫利昔单抗还是阿达木单抗用于克罗恩病？

Aliment Pharmacol Ther. 2012 Aug;36(4):398. doi: 10.1111/j.1365-2036.2012.05167.x.

Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study.抗 TNF-α 治疗与克罗恩病的梗阻症状：一项前瞻性研究。

Dig Liver Dis. 2013 Mar;45(3):258-62. doi: 10.1016/j.dld.2012.10.009. Epub 2012 Nov 26.

Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.克罗恩病患儿中与英夫利昔单抗相关的银屑病可能需要停用抗肿瘤坏死因子治疗。

Inflamm Bowel Dis. 2013 Apr;19(5):E75-7. doi: 10.1097/MIB.0b013e3182802c93.

引用本文的文献

Three-year outcomes of tumor necrosis factor alpha inhibitor therapy in rheumatoid arthritis patients with elevated liver enzymes.类风湿关节炎患者肝酶升高时肿瘤坏死因子α抑制剂治疗的三年结局

World J Hepatol. 2025 Jul 27;17(7):108051. doi: 10.4254/wjh.v17.i7.108051.

Certolizumab-Induced Liver Injury in Ankylosing Spondylitis: A Case Report and Causality Assessment.英夫利昔单抗诱导的强直性脊柱炎肝损伤：一例报告及因果关系评估

Cureus. 2024 Aug 10;16(8):e66569. doi: 10.7759/cureus.66569. eCollection 2024 Aug.

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases.关注抗肿瘤坏死因子 (TNF)-α 相关自身免疫性疾病。

Int J Mol Sci. 2023 May 3;24(9):8187. doi: 10.3390/ijms24098187.

Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.生物制剂和检查点抑制剂所致肝损伤：一项系统文献综述

Hepatol Commun. 2020 Jan 2;4(2):172-184. doi: 10.1002/hep4.1465. eCollection 2020 Feb.

Infliximab-induced autoimmune hepatitis requiring liver transplantation.英夫利昔单抗诱导的自身免疫性肝炎，需进行肝移植。

Clin Case Rep. 2019 Sep 27;7(11):2135-2139. doi: 10.1002/ccr3.2456. eCollection 2019 Nov.

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.抗肿瘤坏死因子-α（TNF-α）对肝脏的有害影响和潜在益处。

Int J Mol Sci. 2018 Jul 27;19(8):2199. doi: 10.3390/ijms19082199.

Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.自身免疫性肝炎与抗肿瘤坏死因子α治疗：单中心8例报告

World J Gastroenterol. 2015 Jun 28;21(24):7584-8. doi: 10.3748/wjg.v21.i24.7584.

Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.抗肿瘤坏死因子药物与肝损伤：文献综述及管理建议

World J Gastroenterol. 2014 Dec 14;20(46):17352-9. doi: 10.3748/wjg.v20.i46.17352.

Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.炎症性肠病中抗TNF-α治疗继发的肝损伤：病例系列及文献综述

Case Rep Gastrointest Med. 2014;2014:956463. doi: 10.1155/2014/956463. Epub 2014 Jan 19.

Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.肿瘤坏死因子-α拮抗剂致肝损伤：34 例分析。

Clin Gastroenterol Hepatol. 2013 May;11(5):558-564.e3. doi: 10.1016/j.cgh.2012.12.025. Epub 2013 Jan 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验